Skip to content
Relatix Bio

Relatix Bio

Radically different

  • Services
  • Knowledgebase
  • Partnerships
  • Our Approach
  • Contact
  • About
    • Vision
    • Our mission
    • Privacy Policy
    • FAQ
    • News
Posted on June 25, 2026 by admin

Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial

Nature Medicine, Published online: 24 June 2026; doi:10.1038/s41591-026-04508-1

Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial

CategoriesImported News TagsClinical trial, Medication

Post navigation

Previous PostPrevious Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
Next PostNext Associations between childhood trauma, intolerance of uncertainty, and symptom severity in obsessive-compulsive disorder

This is the footer

Privacy Policy Proudly powered by WordPress